交易中 03-27 10:03:21 美东时间
0.000
0.00%
开放青岛,积极走出去。 9月22日至26日,市委书记曾赞荣率青岛市代表团先后到泰国、柬埔寨访问。代表团深入贯彻习近平外交思想和习近平总书记对山东、对青岛工作的重...
2025-09-26 15:27
(来源:铑财) 今年恰逢“闰六月”,闷热天气让啤酒消费旺季更旺。 8月7日,为期一个月的青岛国际啤酒节如火如荼,消费热潮频出。当海风裹挟麦芽醇香掠过金...
2025-08-07 20:25
(来源:云酒头条) 当代啤酒消费逻辑正从"佐餐饮品"转向"社交饮品",对于饮酒场景有着更高的追求。青岛国际啤酒节消费数据印证啤酒市场趋势,企业应重构供...
2025-08-02 11:51
8月1日,近日第35届青岛国际啤酒节正在举行。本届啤酒节首次推出专属IP定制酒,上新RADLER新产品。此次RADLER新品推出的两款不同口味,一款为柠檬味...
2025-08-01 22:01
动力煤价格方面:本周秦港价格周环比增加,产地大同价格周环比上涨。港口动力煤:截至7月12日,秦皇岛港动力煤(Q5500)山西产市场价624元/吨,周环比上涨8元...
2025-07-14 14:32
Radiopharm Theranostics has dosed the first patient in a Phase 1 trial of 177Lu-RAD202, targeting HER2-positive advanced solid tumors. The 'HEAT' trial aims to assess safety, tolerability, and efficacy of this novel radiotherapeutic, with earlier data supporting its potential. The study is conducted across Australia, targeting patients with aggressive cancers like breast, ovarian, and gastric. This milestone underscores the company's commitment to addressing unmet needs in oncology.
2025-06-04 12:00
Radiopharm Theranostics announced favorable preclinical data for RV01, a B7-H3-targeted radiopharmaceutical, showing high tumor uptake and favorable biodistribution. The modified monoclonal antibody has a shorter half-life, reducing off-target exposure and potential toxicities. IND submission is expected mid-2025, with a first-in-human Phase 1 study planned for Q4 2025.
2025-06-02 12:00